The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

about

Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.Generic immunosuppressants.Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs.

P2860

Q38610665-EE6BEFB9-9557-43BA-A401-97A0169CF19C Q39451470-4239E4B2-296C-472D-A9E5-805018E18D6B Q48133794-BB9EC514-DD29-47C3-B3E0-E0A757C57D44

P2860

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

Item

http://www.wikidata.org/entity/Q38752528

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

@en

type

Item

label

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

@en

prefLabel

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

@en

P1476

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

@en

P2093

Ana Catalina Alvarez-Elías

http://www.w3.org/2001/XMLSchema#string

Christopher McIntyre

http://www.w3.org/2001/XMLSchema#string

P2860

Developmental aspects of human hepatic drug glucuronidation in young children and adults

Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice.

Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection.

Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience.

Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.

Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring

UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.

P2888

s00467-016-3352-2

P304

21-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-016-3352-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Filler

Mara Medeiros

P577

2016-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296193638

http://www.w3.org/2001/XMLSchema#string

P6179

1027140890

http://www.w3.org/2001/XMLSchema#string

P698

26921212

http://www.w3.org/2001/XMLSchema#string

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

about

P2860

P2860

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698